adjusted us Heather. Results and today with Good quarter, you, joining XXXX gross Medical's net you along Webcast. Rockwell improved growth for reporting another our value. optimizing Call of for last every X Thank Rockwell quarters. and drive improve, had profit sales good our net First and to morning, Quarter and quarter over business sixth in thank Conference cash of are as progress EBITDA continue and business our loss we flow fundamentals the we on focus The profitability, increased making day shareholder and meaningful to
the the hemodialysis our the Let's time, take now Evoqua, concentrates a in U.S. space the of happening consolidated With has acquisition market concentrates last player market. the minute hemodialysis the the year and at XX,XXX what's discuss from only sits Rockwell #X in X business the clinics. supplier concentrates dialysis the over players with this in-center hospital-based to of primary as to the and With now to clinics consolidation, and States. scale distribution United supply these in independent service
hemodialysis market. inherent a value we In for the reflect beginning are to addition, this to What able price liquid At in bring now mean adjust country. the new providers. the Rockwell does to this to bicarbonate pricing our products year, accurately is supplier of program Rockwell? our undertook our leading the product the First, we products in of
censuses patient pre-COVID seeing are providers dialysis leading Second, return to levels.
product again from previously Rockwell. while are growing now volumes already from volumes So who customers concentrates concentrate stagnated, purchased
the and medical market distributors, products nursing increasing for demand suppliers we and dialysis systems, from equipment inside with along States. outside our to continue facilities centers interest in Additionally, United see skilled and health
we a Third, customers over competitor. convert of our seen to number have from primary Rockwell
not to while always expand It's customers, agreements of important a always our announce our new publicity these within restrictions. permit permitted for note to are able continue we agreements continue variety not we -- existing with we reasons, addition, -- including existing new and In sales add base. that to to customers expand able customer to
paradigm take to will working are this We time. but change change
Bottom we are line, to the we market of prepared favorable full take are in advantage these and believe direction, underlying dynamics. this all Rockwell's moving fundamentals of
first During entered and we Rockwell's subsequently into within and several may the internationally. to agreement and both expanded able announce agreements sell, Republic. and quarter, distribute through We which the into Dominican products BioNuclear concentrates hemodialysis were import, entered X-year distribution a domestically promote BioNuclear new with
to and BioNuclear the will beyond agreement the X for The an in term. effect option extend for agreement has remain years, years original X the additional
in We we system of also with Under offer. West systems cleaning hemodialysis this of concentrates additional U.S. largest and terms X the supply entered acid into the the and the other health new with will health in of liquid quarter. bicarbonate region company's and concentrates, products agreement, agreement the dry Mountain purchase this mixers hemodialysis agents, the Rockwell product a first
leading entered time addition, an of In for which acute to care markets. products for option and XXXX, a extend signed has a equipment Bermuda's with been we existing into we customer, supplier International, medical AMI distribution distributor of products since the which agreement agreement. AMI with at expanded is X-year an that Atlantic and Medical Rockwell continuing distribution agreement
purchasing with X just for The their amended support in guidance commitments and profit U.S. agreement a is Rockwell new AMI generate clinics. existing Rockwell have the we supply AMI the consistent between and Medical's from margin margin which for expands of of customers us, and list includes distribution our hemodialysis expanded XXXX. AMI products will increased distribution to and is several that gross volumes purchasing
record hemodialysis $XX.X gross products. During $X.X we of the concentrates net exclusively XXXX, million, million our sales with of first quarter profit of generated and record
XX%, our and and margin was our upward through enhanced believe of trend We processes to margin the continue first will optimize the automated capabilities improved our to highest technology date. quarter gross solutions. gross modernization manufacturing distribution we the infrastructure through it's as further Additionally, for been business
we $XX results, sales for we As have adjusted now quarter and represents first XX% guidance expanded increases be million between contracts a a upward updated to result initial sales million. guidance XXXX over net product million, to of $XX.X to increase for our an $XX new million and our from XXXX. expect volume and our XXXX net guidance in as follows: projected considering for of XX% million sales $XX our This net $XX increase
for of be gross updated XXXX. XX% a expect gross million to $XX million guidance between This $XX represents profit our of now XXXX and million $XX guidance $XX increase to million. We over in XX% an million, profit $X.X increase initial from gross profit to
will to million. which on This our an guidance adjusted initial profitability a turn of $X.X to over XXXX. the Jesse we an basis and adjusted first EBITDA into over to profitable million and adjusted and between financial EBITDA call million a between increase on basis XXX% quarter XXXX. XXX% in $X that, updated our results the an EBITDA $X.X increase now loss Lastly, I represents million, basis from expect With an delve of $X represents for be $X.X of now on